Lisa M. Bartnikas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lisa M. Bartnikas has a total of 137 co-authors. Here are the top co-authors by number of shared publications:
Wanda Phipatanakul
9 shared publicationsLinda J. Herbert
7 shared publicationsMichael C. Young
7 shared publicationsScott H. Sicherer
6 shared publications- Wanda Phipatanakul
Department of Allergy and Immunology, Boston Children's Hospital, Boston, Mass; Department of Pediatrics, Harvard Medical School, Boston, Mass
6 shared publications Roxanne Dupuis
5 shared publications
Latest Publications
- Open Access
- 14 August 2026
- Published by Elsevier in Journal of Allergy and Clinical Immunology: Global
- Vol. 5 (6)
Identifying unmet needs in food protein–induced enterocolitis syndrome using search query analysis and a large language model
- 14 August 2026
- Published by Elsevier in Journal of Allergy and Clinical Immunology: Global
- Vol. 5 (6)
Open AccessIdentifying unmet needs in food protein–induced enterocolitis syndrome using search query analysis and a large language model
- 5 October 2025
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 136 (1) , 33-40
Psychosocial impact and multidisciplinary care of food protein-induced enterocolitis syndrome
- 5 October 2025
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 136 (1) , 33-40
Psychosocial impact and multidisciplinary care of food protein-induced enterocolitis syndrome
- 27 September 2025
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 136 (1) , 7-8
Why an allergist should see another allergist
- 27 September 2025
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 136 (1) , 7-8
Why an allergist should see another allergist
- Open Access
An Evaluation of Food Allergy Management Practices in a Sample of Canadian and American Schools
Background: Children, including the estimated 7% with food allergy, spend most of their waking hours in school. Variations in school-based food allergy (FA) practices exist. We aimed to examine differences in FA management practices across schools in Canada and the United States (US). Methods: Parents of children with Immunoglobulin E (IgE)-mediated FA were recruited through social media to complete a survey evaluating the schools’ stock epinephrine, epinephrine storage locations, school type, and location. Data were described, analyzed using logistic and linear regressions, and then reported as odds ratios (ORs) and standardized coefficients (b), respectively, with corresponding 95% confidence intervals (95%CIs) and p < 0.05. This study was approved by the University of Manitoba Health Research Ethics Board. Results: Overall, 177 participants (14% [26/177] Canada, 86% [151/177] US) were included. Children were, on average, 4.92 ± 3.12 years and were commonly but not mutually exclusively allergic to tree nuts (50% Canada; 40% US) and peanuts (33% Canada; 29% US). Compared to US parents, Canadian parents were more likely to report epinephrine self-carriage by their children (OR = 4.58; 95%CI = 1.67–12.59). Parents with children age > 5 years were more likely to report epinephrine self-carriage by their children (OR = 3.70; 95%CI = 1.38–9.93) but less likely to report that their children’s school had an allergen-friendly zone (OR = 0.25; 95%CI = 0.06–0.99). Compared to US parents, Canadian parents were more likely to report their child’s school had anaphylaxis management policies (OR = 8.98; 95%CI = 1.11–72.42). Conclusions: Significant in-school FA management differences exist between countries. These findings stress the need for consistent policies and practices to ensure effective care.
Open AccessAn Evaluation of Food Allergy Management Practices in a Sample of Canadian and American Schools
Background: Children, including the estimated 7% with food allergy, spend most of their waking hours in school. Variations in school-based food allergy (FA) practices exist. We aimed to examine differences in FA management practices across schools in Canada and the United States (US). Methods: Parents of children with Immunoglobulin E (IgE)-mediated FA were recruited through social media to complete a survey evaluating the schools’ stock epinephrine, epinephrine storage locations, school type, and location. Data were described, analyzed using logistic and linear regressions, and then reported as odds ratios (ORs) and standardized coefficients (b), respectively, with corresponding 95% confidence intervals (95%CIs) and p < 0.05. This study was approved by the University of Manitoba Health Research Ethics Board. Results: Overall, 177 participants (14% [26/177] Canada, 86% [151/177] US) were included. Children were, on average, 4.92 ± 3.12 years and were commonly but not mutually exclusively allergic to tree nuts (50% Canada; 40% US) and peanuts (33% Canada; 29% US). Compared to US parents, Canadian parents were more likely to report epinephrine self-carriage by their children (OR = 4.58; 95%CI = 1.67–12.59). Parents with children age > 5 years were more likely to report epinephrine self-carriage by their children (OR = 3.70; 95%CI = 1.38–9.93) but less likely to report that their children’s school had an allergen-friendly zone (OR = 0.25; 95%CI = 0.06–0.99). Compared to US parents, Canadian parents were more likely to report their child’s school had anaphylaxis management policies (OR = 8.98; 95%CI = 1.11–72.42). Conclusions: Significant in-school FA management differences exist between countries. These findings stress the need for consistent policies and practices to ensure effective care.
- 9 April 2025
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 36 (4) , e70081
Food allergy‐related bullying: Risk factors and psychosocial functioning
Background: Food allergy (FA)‐related bullying is common, yet little is known about risk factors for FA‐related bullying or the relationship between FA‐related bullying and psychosocial wellbeing. This study aimed to (1) identify sociodemographic and clinical factors associated with risk of FA‐related bullying in children with FA, and (2) evaluate the psychosocial functioning of children and parents reporting FA‐related bullying. Methods: This was a cross‐sectional survey study of children ages 5–17 years with immunoglobulin E (IgE)‐mediated FA and their parents, recruited from Boston Children's Hospital (BCH) and through social media outlets. Children and parents with versus without a history of FA‐related bullying were compared on sociodemographic and clinical characteristics and FA‐related psychosocial outcomes using validated instruments. Results: In this cohort of 295 child–parent dyads, the median child age was 8.0 years, 53.2% of children were male, and parent respondents were primarily mothers (96.6%). Reported lifetime prevalence of FA‐related bullying was 36.6%. FA‐related bullying was associated with certain child characteristics, including coming from a household at risk of food insecurity (FI) (12.0% of bullied children v. 2.2% of not bullied children were from food insecure households, p < .001), having coexisting atopic and mental health conditions—particularly anxiety (30.6% of bullied children v. 8.6% of not bullied children carried an anxiety disorder diagnosis, p < .001)—and having a history of more severe FA reactions. FA‐related bullying was associated with elevated concerns in child and parental FA‐related psychosocial functioning domains. Conclusion: Pediatricians and allergists should screen for FA‐related bullying and offer families appropriate guidance around management of FA‐related bullying.
- 9 April 2025
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 36 (4) , e70081
Food allergy‐related bullying: Risk factors and psychosocial functioning
Background: Food allergy (FA)‐related bullying is common, yet little is known about risk factors for FA‐related bullying or the relationship between FA‐related bullying and psychosocial wellbeing. This study aimed to (1) identify sociodemographic and clinical factors associated with risk of FA‐related bullying in children with FA, and (2) evaluate the psychosocial functioning of children and parents reporting FA‐related bullying. Methods: This was a cross‐sectional survey study of children ages 5–17 years with immunoglobulin E (IgE)‐mediated FA and their parents, recruited from Boston Children's Hospital (BCH) and through social media outlets. Children and parents with versus without a history of FA‐related bullying were compared on sociodemographic and clinical characteristics and FA‐related psychosocial outcomes using validated instruments. Results: In this cohort of 295 child–parent dyads, the median child age was 8.0 years, 53.2% of children were male, and parent respondents were primarily mothers (96.6%). Reported lifetime prevalence of FA‐related bullying was 36.6%. FA‐related bullying was associated with certain child characteristics, including coming from a household at risk of food insecurity (FI) (12.0% of bullied children v. 2.2% of not bullied children were from food insecure households, p < .001), having coexisting atopic and mental health conditions—particularly anxiety (30.6% of bullied children v. 8.6% of not bullied children carried an anxiety disorder diagnosis, p < .001)—and having a history of more severe FA reactions. FA‐related bullying was associated with elevated concerns in child and parental FA‐related psychosocial functioning domains. Conclusion: Pediatricians and allergists should screen for FA‐related bullying and offer families appropriate guidance around management of FA‐related bullying.
- 26 March 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 13 (6) , 1481-1484.e2
Childhood food allergy and participation in free or reduced-price meal programs at school
- 26 March 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 13 (6) , 1481-1484.e2
Childhood food allergy and participation in free or reduced-price meal programs at school
- 17 October 2024
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 13 (1) , 241-243.e2
Disparities in pediatric seafood allergy by social determinants of health
- 17 October 2024
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 13 (1) , 241-243.e2
Disparities in pediatric seafood allergy by social determinants of health
- 3 July 2023
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 11 (10) , 3257-3259.e2
Parental awareness and management of bullying in children with food allergies
- 3 July 2023
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 11 (10) , 3257-3259.e2
Parental awareness and management of bullying in children with food allergies
- Open Access
- 15 June 2023
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (12)
Human inherited complete STAT2 deficiency underlies inflammatory viral diseases
STAT2 is a transcription factor activated by type I and III IFNs. We report 23 patients with loss-of-function variants causing autosomal recessive (AR) complete STAT2 deficiency. Both cells transfected with mutant STAT2 alleles and the patients’ cells displayed impaired expression of IFN-stimulated genes and impaired control of in vitro viral infections. Clinical manifestations from early childhood onward included severe adverse reaction to live attenuated viral vaccines (LAV) and severe viral infections, particularly critical influenza pneumonia, critical COVID-19 pneumonia, and herpes simplex virus type 1 (HSV-1) encephalitis. The patients displayed various types of hyperinflammation, often triggered by viral infection or after LAV administration, which probably attested to unresolved viral infection in the absence of STAT2-dependent types I and III IFN immunity. Transcriptomic analysis revealed that circulating monocytes, neutrophils, and CD8+ memory T cells contributed to this inflammation. Several patients died from viral infection or heart failure during a febrile illness with no identified etiology. Notably, the highest mortality occurred during early childhood. These findings show that AR complete STAT2 deficiency underlay severe viral diseases and substantially impacts survival.
- 15 June 2023
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (12)
Open AccessHuman inherited complete STAT2 deficiency underlies inflammatory viral diseases
STAT2 is a transcription factor activated by type I and III IFNs. We report 23 patients with loss-of-function variants causing autosomal recessive (AR) complete STAT2 deficiency. Both cells transfected with mutant STAT2 alleles and the patients’ cells displayed impaired expression of IFN-stimulated genes and impaired control of in vitro viral infections. Clinical manifestations from early childhood onward included severe adverse reaction to live attenuated viral vaccines (LAV) and severe viral infections, particularly critical influenza pneumonia, critical COVID-19 pneumonia, and herpes simplex virus type 1 (HSV-1) encephalitis. The patients displayed various types of hyperinflammation, often triggered by viral infection or after LAV administration, which probably attested to unresolved viral infection in the absence of STAT2-dependent types I and III IFN immunity. Transcriptomic analysis revealed that circulating monocytes, neutrophils, and CD8+ memory T cells contributed to this inflammation. Several patients died from viral infection or heart failure during a febrile illness with no identified etiology. Notably, the highest mortality occurred during early childhood. These findings show that AR complete STAT2 deficiency underlay severe viral diseases and substantially impacts survival.